Navigation Links
Martek Announces Second Quarter 2008 Financial Results
Date:6/4/2008

t formula and supplements, and life'sARA(TM) (arachidonic acid), an omega-6 fatty acid, for use in infant formula. For more information on Martek Biosciences, visit http://www.martek.com.

MARTEK BIOSCIENCES CORPORATION

Summary Consolidated Financial Information

(Unaudited - $ in thousands, except per share data)

Condensed Consolidated Statements of Income Data

Three months ended Six months ended

April 30, April 30,

2008 2007 2008 2007

Revenues:

Product sales $87,875 $72,336 $166,484 $139,048

Contract manufacturing

sales 2,851 4,350 7,123 7,899

Total revenues 90,726 76,686 173,607 146,947

Cost of revenues:

Cost of product sales 50,579 45,817 95,676 88,786

Cost of contract

manufacturing sales 2,764 4,192 6,452 7,615

Total cost of revenues 53,343 50,009 102,128 96,401

Gross margin 37,383 26,677 71,479 50,546

Operating expenses:

Research and development 6,819 6,033 12,800 11,975

Selling, general and

administrative 14,234 10,488 27,215 21,120

Amortization of intangible

assets 1,877 1,373 3,556 2,919

Restructuring charge - 83 - 601

Other operating expenses 96 623 249 1,096

Total operating

expenses 23,026 18,600 43,820 37,711

Income from opera
'/>"/>

SOURCE Martek Biosciences Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Martek to Announce Third Quarter 2007 Results on September 5, 2007
2. Martek to Present at Upcoming UBS Conference
3. Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
4. Martek Announces Settlement of OmegaTech Milestone Litigation
5. Martek to Obtain Permanent Injunction Against Lonza in U.S. Patent Infringement Suit; Jury Verdict on Infringement of Two of Three Patents Upheld by Judge
6. European Patent Office Upholds Martek European DHA Food Patent; Scope of Original Claims Narrowed
7. Martek to Present at Upcoming ThinkEquity Partners Conference
8. Martek Announces Fourth Quarter and FY 2007 Financial Results
9. Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
10. Leading DHA Expert and Former NIH Researcher, Dr. Norman Salem, Jr., to Join Martek as Chief Scientific Officer
11. Challenge Spreadable Butter Now Features Marteks lifesDHA(TM)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... Jan. 22, 2015  Transwestern | RBJ today announces the firm ... space for Shire a leading biopharmaceutical company, at Two Ledgemont ... RBJ,s Robert Richards , president, and Brian Cohen ... the entire five-floor building at 95 Hayden Ave. ...
(Date:1/22/2015)... (PRWEB) January 22, 2015 The laboratory ... that has witnessed a number of technological advancements due ... regulatory requirements, growing need to integrate healthcare systems, and ... ease challenges in system integration. Key players in the ...
(Date:1/22/2015)... January 22, 2015 zFlo Motion , ... to announce an exciting product from a new partner. ... solutions over the past 15 years, with offerings in the ... their 3D IMU system (inertial measurement unit), iSen, is opening ...
(Date:1/22/2015)... Diagenode, Inc., a leading global ... and complete solutions for epigenetics research, recently launched ... the need for manual processing. The new ChIPettor ... of histones or transcription factors and a semi-automated ...
Breaking Biology Technology:Transwestern | RBJ Advises Shire in 202,000 SF Lease, Creating Boston's Largest Suburban Biotech Campus 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 2Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 3Laboratory Information Management Systems Market is Expected to Reach $1,323.6 Million by 2019 - New Research Report by MarketsandMarkets 43D Motion Capture Just Got Easy 2Diagenode Launches Unique Semi-Automated Solution for Chromatin Immunoprecipitation 2
... (LSE: SHP,NASDAQ; SHPGY), announces that it has received a Paragraph IV Notice Letter,from Teva Pharmaceuticals USA, Inc. ("Teva") advising of the filing of ... ... , , ... ...
... 16 OrthoAccel Technologies, Inc. is among the over 100 companies and technology innovators from across the nation and around the world that will compete for top honors at the ... ... ... ...
... ... Dana-Farber/Harvard Cancer Center, Cell Signaling Technology, Harvard Medical School and Merrimack Pharmaceuticals collaborated ... to study efficacy in preclinical cancer models resistant to other targeted therapies. ... Cambridge, ...
Cached Biology Technology:Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 2Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 3Shire Receives INTUNIV (TM) Paragraph IV Notice Letter From Teva Pharmaceuticals 4OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase 2OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase 3OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase 4OrthoAccel Technologies, Inc. Selected to Pitch at the 2010 WBTshowcase 5'Cancer Research' Has Published a Paper on the Activity of MM-121, an ErbB3 Inhibitor, in Ligand-dependent Tumors 2
(Date:12/17/2014)... 16, 2014 Valencell, a leader in performance biometric ... to industry leaders such as Intel, Jabra, Atlas, and ... wearable products. These products will be showcased at CES ... Vegas . "Our partners choose ...
(Date:12/11/2014)... , Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/twhjll/biometrics_market ) has announced the addition of ...  report to their offering. One major ... With continuous advances in technology, it is important to ...
(Date:12/10/2014)... You,ve been here before: you desperately need to sign into ... or the answer to your secret question. What,s your dog,s birthday? ... Hoyos Labs , a digital infrastructure security company, launches the ... that comes with usernames, passwords and PINs – 1U TM ...
Breaking Biology News(10 mins):Valencell PerformTek Biometrics Power the Most Accurate Wearables at CES 2015 2Biometrics Market in the APAC Region 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3
... Company reports quarterly earnings and deepens customer relationships, ... (OTC Bulletin Board: BKYI), a leader in wireless ... its,financial results for the second quarter ended June ... for the three months ended,June 30, 2007 decreased ...
... at the Max Planck Institute of Developmental Biology and ... discovered that an autoimmune response, triggered by a small ... a viable offspring. Studying Arabidopsis thaliana, sometimes called ... paired together from a male and female, produced plants ...
... to target and destroy foreign infectious elements, but in the ... the immune system off to avoid damage to oneself by ... good model for the induction of an innate immune response, ... the flys immune response is more subtly regulated and produces ...
Cached Biology News:BIO-key Reports Second Quarter 2007 Results 2BIO-key Reports Second Quarter 2007 Results 3BIO-key Reports Second Quarter 2007 Results 4BIO-key Reports Second Quarter 2007 Results 5Auto immune response creates barrier to fertility; could be a step in speciation 2
Many mammalian cell types and experimental situations create challenges for standard transfection experiments. The ViraPower Lentiviral Expression System overcomes these challenges with efficient...
Chlorine-36, 3.7 MBq, 100 uCi. 0.1-0.3 HCl.< 111 MBq/g Cl, < 3 mCi/g Cl.Dispensed to order. Please inquire for alternative pack sizes. Category: Radiochemicals &Radiation Safety, Radiochemicals....
1M stock solution (238mg/ml)...
...
Biology Products: